March 01, 2017
Les résultats de l’étude SARA-PK confirment le bon profil pharmacocinétique de Sarconeos chez le sujet âgé. Lire le communiqué de presse
February 21, 2017
Biophytis relocates to Pierre and Marie Curie University (UPMC) campus and solidifies creation of leading translational platform for age-related disease. Read the Press Release
January 05, 2017
BIOPHYTIS to participate to the JP Morgan Annual Healthcare Conference in San Francisco, January 9-12th 2017. Read the Press Release.
December 16, 2016
Biophytis presents preliminary clinical data of SARA-PK, and new preclinical data of Sarconeos for treating sarcopenia. Read the Press Release
November 29, 2016
BIOPHYTIS Announces Successful Completion of SARA-PK Clinical Study for Sarconeos in Sarcopenia Confirming Safety Profile. Read the Press Release
November 28, 2016
Conférence Biotech Agora – December 13, 2016 18h45 – Hôtel ATALA, 10 Rue de Chateaubriand, 75008
november 22, 2016
BIOPHYTIS received regulatory authorizations to conduct SARA-OBS study in sarcopenia patients. Read the Press Release
November 15, 2016
Biophytis Presenting Four Posters on Sarconeos at 9th International Conference on Cachexia, Sarcopenia, and Muscle Wasting. Read the Press Release
November 09, 2016
BIOPHYTIS to attend to Jefferies conference (London) and European Midcap event (Geneva). Read the Press Release
October 24, 2016
BIOPHYTIS chooses Patheon to produce the clinical batches of Macuneos, its AMD drug candidate that will enter Phase 2B. Read the Press Release